Search Results - Emma Verner

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström macroglobulinemia by Jad Othman, Emma Verner, Constantine S. Tam, Jane Huang, Leo Lin, James Hilger, Judith Trotman, Robin Gasiorowski

    Published in Haematologica (2018-05-01)
    Get full text
    Article


  2. 2

    P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL... by Shaun Fleming, John Reynolds, Ashish Bajel, Nicola Venn, John Kwan, John Moore, David Yeung, Nalini Pati, Michael Leahy, Sushma Kollipara, Emma Verner, Leanne Berkahn, Rosemary Sutton, Andrew Wei, Matthew Greenwood

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    P1127: FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Emma Verner, Amanda Johnston, Nalini Pati, Eliza Hawkes, Hui Peng Lee, Tara Cochrane, Chan Yoon Cheah, Robin Filshie, Duncan Purtill, Hanlon Sia, Anoop K Enjeti, Christina Brown, Nicholas Murphy, Jennifer Curnow, Kenneth Lee, Maher Gandhi, Belinda Butcher, Judith Trotman

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALY... by Adrian Minson, Emma Verner, Pratyush Giri, Shu Min Wong, Sumita Ratnasingam, Jason Butler, Wojciech Janowski, Matthew Ku, Chan Cheah, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas Yannakou, Paul Neeson, Javad Saghebi, Piers Blombery, Molly Robertson, Lei Shong Lau, Jing Xie, John Seymour, Michael Dickinson

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  5. 5

    Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion by Constantine S. Tam, Tadeusz Robak, Paolo Ghia, Brad S. Kahl, Patricia Walker, Wojciech Janowski, David Simpson, Mazyar Shadman, Peter S. Ganly, Luca Laurenti, Stephen Opat, Monica Tani, Hanna Ciepluch, Emma Verner, Martin Šimkovič, Anders Österborg, Marek Trněný, Alessandra Tedeschi, Jason C. Paik, Sowmya B. Kuwahara, Shibao Feng, Vanitha Ramakrishnan, Aileen Cohen, Jane Huang, Peter Hillmen, Jennifer R. Brown

    Published in Haematologica (2020-10-01)
    Get full text
    Article


  6. 6

    Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study by Michael K. Odutola, Marina T. van Leeuwen, Julie K. Bassett, Fiona Bruinsma, Jennifer Turner, Jennifer Turner, John F. Seymour, Henry Miles Prince, Samuel T. Milliken, Mark Hertzberg, Fernando Roncolato, Fernando Roncolato, Stephen S. Opat, Robert Lindeman, Campbell Tiley, Judith Trotman, Emma Verner, Michael Harvey, Craig R. Underhill, Geza Benke, Graham G. Giles, Graham G. Giles, Claire M. Vajdic, Claire M. Vajdic

    Published in Frontiers in Nutrition (2023-01-01)
    Get full text
    Article


  7. 7

    P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW... by Talha Munir, Mazyar Shadman, Tadeusz Robak, Jennifer R. Brown, Brad Kahl, Paolo Ghia, Krzysztof Giannopoulos, Martin Simkovic, Anders Österberg, Luca Laurenti, Patricia Walker, Stephen Opat, Hanna Ciepluch, Richard Greil, Merit Hanna, Monica Tani, Marek Trneny, Danielle M. Brander, Ian W. Flinn, Sebastian Grosicki, Emma Verner, Alessandra Tedeschi, Sophie De Guibert, Gayane Tumyan, Kamel Laribi, Jose Antonio Garcia Marco, Jianyong LI, Tian Tian, Vanitha Ramakrishnan, Yu Liu, Andy Szeto, Jason Paik, Aileen Cohen, Constantine Tam, Wojciech Jurczak

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? by Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

    Published in Blood Cancer Journal (2024-03-01)
    Get full text
    Article


Search Tools: